Prospective evaluation of metabolic syndrome and its components among long-term liver recipients

Liver International

Volumn 34, Issue 7, 2014, Pages 1094-1101

  Anastácio, Lucilene R ^a   Diniz, Kiara G ^a   Ribeiro, Hélem S ^a   Ferreira, Lívia G ^a   Lima, Agnaldo S ^a   Correia, Maria Isabel T D ^a   Vilela, Eduardo G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Diabetes mellitus; Immunosuppressive agents; Liver transplantation; Metabolic syndrome; Obesity

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GRAFT RECIPIENT; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE; ADVERSE EFFECTS; BRAZIL; DEMOGRAPHY; DIET; IMPEDANCE; LIFESTYLE; METABOLISM; PHYSIOLOGY; RISK; RISK FACTOR; SOCIOECONOMICS; STATISTICAL MODEL;

BLOOD GLUCOSE; BODY COMPOSITION; BRAZIL; DEMOGRAPHY; DIET; ELECTRIC IMPEDANCE; HUMANS; LIFE STYLE; LIVER TRANSPLANTATION; LOGISTIC MODELS; METABOLIC SYNDROME X; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; WAIST CIRCUMFERENCE;

EID: 84904408875     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12495     Document Type: Article

References (37)

1. Braun F, Teren K, Wilms P, et al. Quality of life after liver transplantation. Transplant Proc 2009; 41: 2564-6.
2. Adam R, Hoti E. Liver transplantation: the current situation. Semin Liver Dis 2009; 29: 3-18.
3. Duffy JP, Kao K, Ko CY, et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg 2010; 252: 652-61.
4. Neuberger J. Liver transplantation. Semin Liver Dis 2009; 29: 1.
5. Simo KA, Sereika S, Bitner N, Newton KN, Gerber DA. Medical epidemiology of patients surviving ten years after liver transplantation. Clin Transplant 2011; 25: 360-7.
6. Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011; 17: 15-22.
7. Anastacio LR, Ferreira LG, de Sena Ribeiro H, et al. Body composition and overweight of liver transplant recipients. Transplantation 2011; 92: 947-51.
8. Anastacio LR, Ferreira LG, Ribeiro Hde S, et al. Metabolic syndrome after liver transplantation: prevalence and predictive factors. Nutrition 2011; 27: 931-7.
9. Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol 2010; 53: 199-206.
10. Sprinzl MF, Weinmann A, Lohse N, et al. Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation. Transpl Int 2013; 26: 67-74.
11. Hanouneh IA, Feldstein AE, McCullough AJ, et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008; 14: 1287-93.
12. Lunati ME, Grancini V, Agnelli F, et al. Metabolic syndrome after liver transplantation: short-term prevalence and pre- and post-operative risk factors. Dig Liver Dis 2013; 45: 833-9.
13. Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl 2008; 14: 1648-54.
14. Laryea M, Watt KD, Molinari M, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007; 13: 1109-14.
15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-266.
16. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.
17. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
18. World Health Organization W. Physical Status: The Use and Interpretation of Anthropometry. (Report of a WHO Expert Committee). Technical Report Series. Genebra: World Health Organization, 1995; 854: 1-452.
19. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32(9 Suppl.): S498-504.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
21. WHO. Obesity: Preventing and Managing The Global Epidemic. Genebra: World Health Organization, 1998.
22. Philippi ST. Tabela de composição de alimentos: suporte para decisão nutricional. ANVISA, ed. Brasília: FINATEC/NUT-UnB, 2001.
23. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2010; 2: 180-93.
24. Salaroli LB, Barbosa GC, Mill JG, Molina MC. Prevalence of metabolic syndrome in population-based study, Vitoria, ES-Brazil. Arq Bras Endocrinol Metabol 2007; 51: 1143-52.
25. Koutsovasilis A, Protopsaltis J, Triposkiadis F, et al. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome. Intern Med 2009; 48: 179-87.
26. Li WJ, Xue H, Sun K, et al. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria. Chin Med J (Engl) 2008; 121: 1532-6.
27. Cortez-Dias N, Martins SR, Belo A, Fiuza M. Association of metabolic risk factors with uncontrolled hypertension: comparison of the several definitions of metabolic syndrome. J Hypertens 2013; 31: 1991-7.
28. Choi KM, Kim SM, Kim YE, et al. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism. 2007; 56: 552-8.
29. Onat A, Ceyhan K, Basar O, et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165: 285-92.
30. Bodziak KA, Hricik DE. New-onset diabetes mellitus after solid organ transplantation. Transpl Int 2009; 22: 519-30.
31. Pageaux GP, Faure S, Bouyabrine H, Bismuth M, Assenat E. Long-term outcomes of liver transplantation: diabetes mellitus. Liver Transpl 2009; 15(Suppl 2): S79-82.
32. Williamson DF. Dietary intake and physical activity as "predictors" of weight gain in observational, prospective studies of adults. Nutr Rev 1996; 54(4 Pt. 2): S101-9.
33. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res 2003; 11: 1223-31.
34. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008; 11: 693-700.
35. Schutz T, Hudjetz H, Roske AE, et al. Weight gain in long-term survivors of kidney or liver transplantation - another paradigm of sarcopenic obesity? Nutrition 2012; 28: 378-83.
36. Figueiredo FA, De Mello Perez R, Kondo M. Effect of liver cirrhosis on body composition: evidence of significant depletion even in mild disease. J Gastroenterol Hepatol 2005; 20: 209-16.
37. Freire RD, Cardoso MA, Gimeno SG, Ferreira SR. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care 2005; 28: 1779-85.